460 related articles for article (PubMed ID: 22134222)
1. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression.
Corbin KD; Zeisel SH
Curr Opin Gastroenterol; 2012 Mar; 28(2):159-65. PubMed ID: 22134222
[TBL] [Abstract][Full Text] [Related]
2. Choline's role in maintaining liver function: new evidence for epigenetic mechanisms.
Mehedint MG; Zeisel SH
Curr Opin Clin Nutr Metab Care; 2013 May; 16(3):339-45. PubMed ID: 23493015
[TBL] [Abstract][Full Text] [Related]
3. Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis.
Corbin KD; Abdelmalek MF; Spencer MD; da Costa KA; Galanko JA; Sha W; Suzuki A; Guy CD; Cardona DM; Torquati A; Diehl AM; Zeisel SH
FASEB J; 2013 Apr; 27(4):1674-89. PubMed ID: 23292069
[TBL] [Abstract][Full Text] [Related]
4. One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and Genetics.
Radziejewska A; Muzsik A; Milagro FI; Martínez JA; Chmurzynska A
Lifestyle Genom; 2020; 13(2):53-63. PubMed ID: 31846961
[TBL] [Abstract][Full Text] [Related]
5. Gene response elements, genetic polymorphisms and epigenetics influence the human dietary requirement for choline.
Zeisel SH
IUBMB Life; 2007 Jun; 59(6):380-7. PubMed ID: 17613168
[TBL] [Abstract][Full Text] [Related]
6. Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes.
Sherriff JL; O'Sullivan TA; Properzi C; Oddo JL; Adams LA
Adv Nutr; 2016 Jan; 7(1):5-13. PubMed ID: 26773011
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in methyl-group metabolism and epigenetics: lessons from humans and mouse models.
Zeisel SH
Brain Res; 2008 Oct; 1237():5-11. PubMed ID: 18789905
[TBL] [Abstract][Full Text] [Related]
8. The transition from fatty liver to NASH associates with SAMe depletion in db/db mice fed a methionine choline-deficient diet.
Wortham M; He L; Gyamfi M; Copple BL; Wan YJ
Dig Dis Sci; 2008 Oct; 53(10):2761-74. PubMed ID: 18299981
[TBL] [Abstract][Full Text] [Related]
9. Roles and Mechanisms of Choline Metabolism in Nonalcoholic Fatty Liver Disease and Cancers.
Chen X; Qiu W; Ma X; Ren L; Feng M; Hu S; Xue C; Chen R
Front Biosci (Landmark Ed); 2024 May; 29(5):182. PubMed ID: 38812309
[TBL] [Abstract][Full Text] [Related]
10. Fat and Sugar-A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease.
Simoes ICM; Janikiewicz J; Bauer J; Karkucinska-Wieckowska A; Kalinowski P; Dobrzyń A; Wolski A; Pronicki M; Zieniewicz K; Dobrzyń P; Krawczyk M; Zischka H; Wieckowski MR; Potes Y
Nutrients; 2019 Nov; 11(12):. PubMed ID: 31771244
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota.
Han R; Ma J; Li H
Front Med; 2018 Dec; 12(6):645-657. PubMed ID: 30178233
[TBL] [Abstract][Full Text] [Related]
12. Choline-related-inherited metabolic diseases-A mini review.
Wortmann SB; Mayr JA
J Inherit Metab Dis; 2019 Mar; 42(2):237-242. PubMed ID: 30681159
[TBL] [Abstract][Full Text] [Related]
13. Tetradecylthiopropionic acid induces hepatic mitochondrial dysfunction and steatosis, accompanied by increased plasma homocysteine in mice.
Berge RK; Bjørndal B; Strand E; Bohov P; Lindquist C; Nordrehaug JE; Svardal A; Skorve J; Nygård O
Lipids Health Dis; 2016 Feb; 15():24. PubMed ID: 26846427
[TBL] [Abstract][Full Text] [Related]
14. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
Xie C; Halegoua-DeMarzio D
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
[TBL] [Abstract][Full Text] [Related]
15. Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology.
Della Corte C; Fintini D; Giordano U; Cappa M; Brufani C; Majo F; Mennini C; Nobili V
Clin Endocrinol (Oxf); 2013 Jul; 79(1):49-54. PubMed ID: 22789032
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
Dietrich P; Hellerbrand C
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease.
Coronel-Castillo CE; Qi X; Contreras-Carmona J; Ramírez-Pérez OL; Méndez-Sánchez N
Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):531-540. PubMed ID: 30905208
[TBL] [Abstract][Full Text] [Related]
19. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.
Honda T; Ishigami M; Luo F; Lingyun M; Ishizu Y; Kuzuya T; Hayashi K; Nakano I; Ishikawa T; Feng GG; Katano Y; Kohama T; Kitaura Y; Shimomura Y; Goto H; Hirooka Y
Metabolism; 2017 Apr; 69():177-187. PubMed ID: 28285648
[TBL] [Abstract][Full Text] [Related]
20. Choline Supplementation Prevents a Hallmark Disturbance of Kwashiorkor in Weanling Mice Fed a Maize Vegetable Diet: Hepatic Steatosis of Undernutrition.
May T; Klatt KC; Smith J; Castro E; Manary M; Caudill MA; Jahoor F; Fiorotto ML
Nutrients; 2018 May; 10(5):. PubMed ID: 29786674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]